369 related articles for article (PubMed ID: 18597077)
1. Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
Egerton A; Ahmad R; Hirani E; Grasby PM
Psychopharmacology (Berl); 2008 Nov; 200(4):487-96. PubMed ID: 18597077
[TBL] [Abstract][Full Text] [Related]
2. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.
Lucas G; Spampinato U
J Neurochem; 2000 Feb; 74(2):693-701. PubMed ID: 10646521
[TBL] [Abstract][Full Text] [Related]
3. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis.
Dewey SL; Smith GS; Logan J; Alexoff D; Ding YS; King P; Pappas N; Brodie JD; Ashby CR
J Neurosci; 1995 Jan; 15(1 Pt 2):821-9. PubMed ID: 7823183
[TBL] [Abstract][Full Text] [Related]
4. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
[TBL] [Abstract][Full Text] [Related]
5. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
6. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Ball KT; Rebec GV
Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
[TBL] [Abstract][Full Text] [Related]
7. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
8. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
9. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.
Smith GS; Ma Y; Dhawan V; Chaly T; Eidelberg D
Synapse; 2009 Jan; 63(1):1-6. PubMed ID: 18925655
[TBL] [Abstract][Full Text] [Related]
11. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
13. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
14. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
[TBL] [Abstract][Full Text] [Related]
15. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
Narendran R; Mason NS; Laymon CM; Lopresti BJ; Velasquez ND; May MA; Kendro S; Martinez D; Mathis CA; Frankle WG
J Pharmacol Exp Ther; 2010 May; 333(2):533-9. PubMed ID: 20103586
[TBL] [Abstract][Full Text] [Related]
17. Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.
Felger JC; Mun J; Kimmel HL; Nye JA; Drake DF; Hernandez CR; Freeman AA; Rye DB; Goodman MM; Howell LL; Miller AH
Neuropsychopharmacology; 2013 Oct; 38(11):2179-87. PubMed ID: 23657438
[TBL] [Abstract][Full Text] [Related]
18. Increased affinity of dopamine for D(2) -like versus D(1) -like receptors. Relevance for volume transmission in interpreting PET findings.
Marcellino D; Kehr J; Agnati LF; Fuxe K
Synapse; 2012 Mar; 66(3):196-203. PubMed ID: 22034017
[TBL] [Abstract][Full Text] [Related]
19. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
20. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
